Immix Biopharma Inc (IMMX) — Defensive Interval Ratio
Immix Biopharma Inc (IMMX) has a Defensive Interval Ratio of 392 days as of March 2026. Defensive assets of $11.33 Million (cash $-, short-term investments $11.33 Million, receivables $-) cover 392 days of daily cash needs of $28.88K/day. Check Immix Biopharma Inc (IMMX) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Immix Biopharma Inc Defensive Interval Ratio (2019–2025)
This chart shows how Immix Biopharma Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 392 days, meaning defensive assets of $11.33 Million can fund 392 days of operations without new revenue. Also explore IMMX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Immix Biopharma Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Immix Biopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see IMMX market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 234 days | $6.48 Million | $27.70K/day | $- | $6.48 Million | ▲ +151 days |
| 2024 | 83 days | $1.97 Million | $23.80K/day | $- | $0.00 | ▼ -32 days |
| 2023 | 115 days | $1.17 Million | $10.20K/day | $- | $- | ▲ +42 days |
| 2022 | 73 days | $255.71K | $3.49K/day | $- | $- | ▲ +27 days |
| 2021 | 46 days | $25.72K | $553.53/day | $- | $- | ▲ +38 days |
| 2020 | 9 days | $127.44K | $14.44K/day | $- | $- | ▼ -5 days |
| 2019 | 14 days | $175.75K | $12.57K/day | $- | $- | — |